Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome

American Journal of Cardiology

Volumn 99, Issue 10, 2007, Pages 1364-1368

  Cavusoglu, Erdal ^a,b   Ruwende, Cyril ^c   Eng, Calvin ^b   Chopra, Vineet ^b   Yanamadala, Sunitha ^c   Clark, Luther T ^a   Pinsky, David J ^c   Marmur, Jonathan D ^a  

^a SUNY Downstate Medical Center   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; MYELOPEROXIDASE; STATIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA BASE; DEATH; DRUG BLOOD LEVEL; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; THORAX PAIN;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; SYNDROME; TIME FACTORS; TROPONIN I;

EID: 34247624608     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.060     Document Type: Article

References (17)

1. Zhang R., Brennan M.L., Fu X., Aviles R.J., Pearce G.L., Penn M.S., Topol E.J., Sprecher D.L., and Hazen S.L. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
2. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., Simoons M.L., and Hamm C.W. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
3. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E.J., Nissen S.E., and Hazen S.L. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
4. Cavusoglu E., Chopra V., Gupta A., Clark L.T., Eng C., and Marmur J.D. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 98 (2006) 580-584
5. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
6. Blankenberg S., Rupprecht H.J., Bickel C., Espinola-Klein C., Rippin G., Hafner G., Ossendorf M., Steinhagen K., and Meyer J. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 103 (2001) 2915-2921
7. Blake G.J., and Ridker P.M. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41 suppl (2003) 37S-42S
8. Mueller C., Buettner H.J., Hodgson J.M., Marsch S., Perruchoud A.P., Roskamm H., and Neumann F.J. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 105 (2002) 1412-1415
9. Cavusoglu E., Chopra V., Gupta A., Ruwende C., Yanamadala S., Eng C., Clark L.T., Pinsky D.J., and Marmur J.D. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography. Am J Cardiol 98 (2006) 1189-1193
10. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., and Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
11. Cavusoglu E., Ruwende C., Chopra V., Yanamadala S., Eng C., Clark L.T., Pinsky D.J., and Marmur J.D. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 27 (2006) 2300-2309
12. Cavusoglu E., Ruwende C., Chopra V., Yanamadala S., Eng C., Clark L.T., Pinsky D.J., and Marmur J.D. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 151 (2006) 1101 e1-8
13. Lubos E., Schnabel R., Rupprecht H.J., Bickel C., Messow C.M., Prigge S., Cambien F., Tiret L., Munzel T., and Blankenberg S. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study. Eur Heart J 27 (2006) 150-156
14. Sundstrom J., Evans J.C., Benjamin E.J., Levy D., Larson M.G., Sawyer D.B., Siwik D.A., Colucci W.S., Wilson P.W., and Vasan R.S. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study. Eur Heart J 25 (2004) 1509-1516
15. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
16. Ng L.L., Pathik B., Loke I.W., Squire I.B., and Davies J.E. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am Heart J 152 (2006) 94-101
17. Tang W.H., Brennan M.L., Philip K., Tong W., Mann S., Van Lente F., and Hazen S.L. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 98 (2006) 796-799